Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Oki M

Japan
Publications

High Risk of Acute Exacerbation of Interstitial Lung Disease In Relapsed Small Cell Lung Cancer Treated With Amrubicin

Background: The safety and efficacy of chemotherapy for relapsed small cell lung cancer (SCLC) with interstitial lung disease (ILD) is uncertain. ILD is a risk factor for acute exacerbation (AE)-ILD. Methods: From January 2009 to December 2017, we retrospectively analyzed relapsed SCLC patients with ILD who received chemotherapy at Nagoya Medical ... Read More»

Niwa H, Torii A, Yamada A, Kogure Y, Kitagawa C, Oki M and Saka H

: J Oncol Res Treat, 2019, 4: 141

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top